IN2015MN00139A - - Google Patents
Download PDFInfo
- Publication number
- IN2015MN00139A IN2015MN00139A IN139MUN2015A IN2015MN00139A IN 2015MN00139 A IN2015MN00139 A IN 2015MN00139A IN 139MUN2015 A IN139MUN2015 A IN 139MUN2015A IN 2015MN00139 A IN2015MN00139 A IN 2015MN00139A
- Authority
- IN
- India
- Prior art keywords
- protein
- fragments
- present
- hetero dimeric
- immunoglobulinvariants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/522—CH1 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/524—CH2 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/526—CH3 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261705278P | 2012-09-25 | 2012-09-25 | |
| PCT/EP2013/069989 WO2014049003A1 (en) | 2012-09-25 | 2013-09-25 | Purification of hetero-dimeric immunoglobulins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015MN00139A true IN2015MN00139A (de) | 2015-10-16 |
Family
ID=49237223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN139MUN2015 IN2015MN00139A (de) | 2012-09-25 | 2013-09-25 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20150239991A1 (de) |
| EP (2) | EP3401337A1 (de) |
| JP (5) | JP2015529236A (de) |
| KR (1) | KR20150076172A (de) |
| CN (1) | CN104968685A (de) |
| AU (2) | AU2013322710A1 (de) |
| CA (2) | CA2886036A1 (de) |
| HK (1) | HK1215950A1 (de) |
| IL (2) | IL237872B (de) |
| IN (1) | IN2015MN00139A (de) |
| WO (1) | WO2014049003A1 (de) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090162359A1 (en) | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
| JP5616428B2 (ja) | 2009-04-07 | 2014-10-29 | ロシュ グリクアート アクチェンゲゼルシャフト | 三価の二重特異性抗体 |
| US9676845B2 (en) | 2009-06-16 | 2017-06-13 | Hoffmann-La Roche, Inc. | Bispecific antigen binding proteins |
| WO2011034605A2 (en) | 2009-09-16 | 2011-03-24 | Genentech, Inc. | Coiled coil and/or tether containing protein complexes and uses thereof |
| AR080793A1 (es) | 2010-03-26 | 2012-05-09 | Roche Glycart Ag | Anticuerpos biespecificos |
| JP5758004B2 (ja) | 2010-08-24 | 2015-08-05 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ジスルフィドによって安定化されたＦｖ断片を含む二重特異性抗体 |
| CA2825081A1 (en) | 2011-02-28 | 2012-09-07 | Birgit Bossenmaier | Antigen binding proteins |
| EP2681240B1 (de) | 2011-02-28 | 2017-08-16 | F. Hoffmann-La Roche AG | Monovalente antigenbindende proteine |
| EP3401337A1 (de) * | 2012-09-25 | 2018-11-14 | Glenmark Pharmaceuticals S.A. | Reinigung von hetero-dimeren immunglobulinen |
| CN105143262A (zh) | 2013-04-29 | 2015-12-09 | 豪夫迈·罗氏有限公司 | 结合人fcrn的修饰的抗体和使用方法 |
| WO2015033223A2 (en) * | 2013-09-03 | 2015-03-12 | Novimmune S.A. | Readily isolated bispecific binding molecules with native format having mutated constant regions |
| KR20160044060A (ko) | 2013-10-11 | 2016-04-22 | 에프. 호프만-라 로슈 아게 | 다중특이적 도메인 교환된 통상의 가변 경쇄 항체 |
| NZ720161A (en) * | 2013-11-04 | 2022-07-29 | Ichnos Sciences SA | Production of t cell retargeting hetero-dimeric immunoglobulins |
| KR20160104636A (ko) * | 2014-01-15 | 2016-09-05 | 에프. 호프만-라 로슈 아게 | 단백질 Ａ-결합이 개선된 Ｆｃ-영역 변이체 |
| US9822186B2 (en) | 2014-03-28 | 2017-11-21 | Xencor, Inc. | Bispecific antibodies that bind to CD38 and CD3 |
| AR101262A1 (es) * | 2014-07-26 | 2016-12-07 | Regeneron Pharma | Plataforma de purificación para anticuerpos biespecíficos |
| EP3174897B1 (de) * | 2014-07-29 | 2020-02-12 | F.Hoffmann-La Roche Ag | Multispezifische antikörper |
| MA40894A (fr) * | 2014-11-04 | 2017-09-12 | Glenmark Pharmaceuticals Sa | Immunoglobulines hétéro-dimères reciblant des lymphocytes t cd3/cd38 et leurs procédés de production |
| US11773166B2 (en) | 2014-11-04 | 2023-10-03 | Ichnos Sciences SA | CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production |
| TN2017000222A1 (en) | 2014-11-26 | 2018-10-19 | Xencor Inc | Heterodimeric antibodies that bind cd3 and cd38 |
| WO2016087416A1 (en) | 2014-12-03 | 2016-06-09 | F. Hoffmann-La Roche Ag | Multispecific antibodies |
| IL301140A (en) * | 2015-10-25 | 2023-05-01 | The Usa As Represented By The Sec Dep Of Health And Human Services | Trispecific and/or terrivalent binding proteins for the prevention or treatment of HIV infection |
| GB201602156D0 (en) * | 2016-02-05 | 2016-03-23 | Jones Philip C And Boku University Of Natural Resources And Life Sciences | Heterodimers and purification thereof |
| DK3443006T5 (da) | 2016-04-13 | 2023-11-06 | Sanofi Sa | Trispecifikke og/eller trivalente bindingsproteiner |
| WO2017180913A2 (en) * | 2016-04-13 | 2017-10-19 | Sanofi | Trispecific and/or trivalent binding proteins |
| JP6675017B2 (ja) * | 2016-05-02 | 2020-04-01 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | コントースボディ−単鎖標的結合物質 |
| AU2017336867B2 (en) * | 2016-09-29 | 2024-03-14 | Beijing Hanmi Pharmaceutical Co., Ltd. | Heterodimeric immunoglobulin constructs and preparation methods thereof |
| EA201990894A9 (ru) | 2016-11-18 | 2019-11-27 | Анти-pd-1/анти-her2 гетеродимерное биспецифическое антитело со структурой природного антитела и способ его получения | |
| CA3058477A1 (en) | 2017-04-11 | 2018-10-18 | Inhibrx, Inc. | Multispecific polypeptide constructs having constrained cd3 binding and methods of using the same |
| WO2019153200A1 (zh) | 2018-02-08 | 2019-08-15 | 北京韩美药品有限公司 | 抗pd-1/抗her2天然抗体结构样异源二聚体形式双特异抗体及其制备 |
| WO2019183334A1 (en) | 2018-03-21 | 2019-09-26 | Waters Technologies Corporation | Non-antibody high-affinity-based sample preparation, sorbents, devices and methods |
| WO2019200022A1 (en) | 2018-04-11 | 2019-10-17 | Inhibrx, Inc. | Multispecific polypeptide constructs having constrained cd3 binding and related methods and uses |
| FR3080621B1 (fr) * | 2018-04-26 | 2022-12-09 | Univ Limoges | Nouvelle classe d'immunoglobuline recombinante de type g : igg5, codee par le pseudo-gene gamma humain de chaine lourde |
| CA3104390A1 (en) | 2018-06-22 | 2019-12-26 | Genmab A/S | Method for producing a controlled mixture of two or more different antibodies |
| CN112789294A (zh) | 2018-07-24 | 2021-05-11 | 印希比股份有限公司 | 含有受限cd3结合结构域和受体结合区的多特异性多肽构建体及其使用方法 |
| CN113166261A (zh) | 2018-10-11 | 2021-07-23 | 印希比股份有限公司 | B7h3单域抗体及其治疗性组合物 |
| TW202021986A (zh) | 2018-10-11 | 2020-06-16 | 美商英伊布里克斯公司 | 5t4單域抗體及其治療性組合物 |
| WO2020076977A2 (en) | 2018-10-11 | 2020-04-16 | Inhibrx, Inc. | Dll3 single domain antibodies and therapeutic compositions thereof |
| CN113166262A (zh) | 2018-10-11 | 2021-07-23 | 英伊布里克斯公司 | Pd-1单结构域抗体及其治疗组合物 |
| EP3902825A1 (de) | 2018-12-24 | 2021-11-03 | Sanofi | Pseudofab-basierte multispezifische bindungsproteine |
| US11613576B2 (en) | 2019-04-09 | 2023-03-28 | Sanofi | Trispecific binding proteins, methods, and uses thereof |
| AU2020414489A1 (en) * | 2019-12-26 | 2022-07-14 | Abl Bio Inc. | Method for purifying biologically active peptide by using protein a affinity chromatography |
| CA3168832A1 (en) | 2020-01-29 | 2021-08-05 | Inhibrx, Inc. | Cd28 single domain antibodies and multivalent and multispecific constructs thereof |
| MX2023004054A (es) | 2020-10-07 | 2023-06-29 | Dren Bio Inc | Anticuerpos anti-dectina 1 y metodos de uso de los mismos. |
| WO2022266221A1 (en) | 2021-06-16 | 2022-12-22 | Alector Llc | Monovalent anti-mertk antibodies and methods of use thereof |
| WO2022266223A1 (en) | 2021-06-16 | 2022-12-22 | Alector Llc | Bispecific anti-mertk and anti-pdl1 antibodies and methods of use thereof |
| WO2023240109A1 (en) | 2022-06-07 | 2023-12-14 | Regeneron Pharmaceuticals, Inc. | Multispecific molecules for modulating t-cell activity, and uses thereof |
| TW202405020A (zh) | 2022-07-29 | 2024-02-01 | 美商阿列克特有限責任公司 | 轉鐵蛋白受體抗原結合域及其用途 |
| WO2024026471A1 (en) | 2022-07-29 | 2024-02-01 | Alector Llc | Cd98hc antigen-binding domains and uses therefor |
| WO2024050493A2 (en) * | 2022-09-02 | 2024-03-07 | Zoetis Services Llc | Equine antibody mutants |
| WO2024102948A1 (en) | 2022-11-11 | 2024-05-16 | Celgene Corporation | Fc receptor-homolog 5 (fcrh5) specific binding molecules and bispecific t-cell engaging antibodies including same and related methods |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| EP0739904A1 (de) | 1989-06-29 | 1996-10-30 | Medarex, Inc. | Bispezifische Reagenzien für die AIDS-Therapie |
| EP0547065B1 (de) | 1990-06-29 | 2001-08-29 | Large Scale Biology Corporation | Melaninproduktion durch transformierte mikroorganismen |
| LU91067I2 (fr) | 1991-06-14 | 2004-04-02 | Genentech Inc | Trastuzumab et ses variantes et dérivés immuno chimiques y compris les immotoxines |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| DE4419399C1 (de) | 1994-06-03 | 1995-03-09 | Gsf Forschungszentrum Umwelt | Verfahren zur Herstellung von heterologen bispezifischen Antikörpern |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| DK0826696T3 (da) | 1996-09-03 | 2002-09-23 | Gsf Forschungszentrum Umwelt | Anvendelse af bi- og trispecifikke antistoffer til inducering af en tumorimmunitet |
| US6322788B1 (en) * | 1998-08-20 | 2001-11-27 | Stanley Arthur Kim | Anti-bacterial antibodies and methods of use |
| US8142780B2 (en) * | 1998-08-20 | 2012-03-27 | Strox Biopharmaceuticals, Llc | Anti-bacterial antibodies |
| EP1896504B1 (de) * | 2005-06-17 | 2012-11-21 | Wyeth LLC | VERFAHREN ZUR REINIGUNG FC-REGIONSHALTIGER ANTIKöRPER |
| AR056857A1 (es) | 2005-12-30 | 2007-10-24 | U3 Pharma Ag | Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos |
| EP1999154B1 (de) | 2006-03-24 | 2012-10-24 | Merck Patent GmbH | Gentechnisch hergestellte heterodimere proteindomänen |
| EP2035456A1 (de) | 2006-06-22 | 2009-03-18 | Novo Nordisk A/S | Herstellung bispezifischer antikörper |
| EP3248617A3 (de) | 2007-02-16 | 2018-02-21 | Merrimack Pharmaceuticals, Inc. | Antikörper gegen erbb3 und verwendungen davon |
| JP6157046B2 (ja) | 2008-01-07 | 2017-07-05 | アムジェン インコーポレイテッド | 静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法 |
| BRPI0919841A2 (pt) * | 2008-10-01 | 2014-11-18 | Micromet Ag | Anticorpo de cadeia unica biespecifico de psmaxcd3, especifico de especies cruzadas |
| EP2382234A2 (de) * | 2008-12-23 | 2011-11-02 | Genentech, Inc. | Immunglobulinvarianten mit veränderter bindung an protein a |
| WO2010095031A2 (en) | 2009-02-23 | 2010-08-26 | Glenmark Pharmaceuticals S.A. | Humanized antibodies that bind to cd19 and their uses |
| SG10201402742YA (en) | 2009-03-20 | 2014-08-28 | Genentech Inc | Bispecific anti-her antibodies |
| KR20120027055A (ko) | 2009-06-26 | 2012-03-20 | 리제네론 파라마큐티칼스 인코포레이티드 | 천연 면역글로불린 포맷을 가지는 용이하게 분리된 이중특이성 항체 |
| ES2777901T3 (es) * | 2009-12-25 | 2020-08-06 | Chugai Pharmaceutical Co Ltd | Método de modificación de polipéptidos para purificar multímeros polipeptídicos |
| US9150663B2 (en) * | 2010-04-20 | 2015-10-06 | Genmab A/S | Heterodimeric antibody Fc-containing proteins and methods for production thereof |
| CA2812739A1 (en) | 2011-03-25 | 2012-10-04 | Glenmark Pharmaceuticals S.A. | Hetero-dimeric immunoglobulins |
| US9114516B2 (en) | 2011-07-21 | 2015-08-25 | Illinois Tool Works Inc. | Portable combustion gas-powered tools with combustion chamber lockout system |
| CN118290588A (zh) * | 2011-10-27 | 2024-07-05 | 健玛保 | 异二聚体蛋白的生成 |
| CN104137107A (zh) | 2012-03-06 | 2014-11-05 | 福斯分析有限公司 | 用于为化学计量分析形成预测模型的方法、软件和图形用户界面 |
| AU2013234039B2 (en) | 2012-03-13 | 2018-02-01 | Novimmune S.A. | Readily isolated bispecific antibodies with native immunoglobulin format |
| EP3401337A1 (de) * | 2012-09-25 | 2018-11-14 | Glenmark Pharmaceuticals S.A. | Reinigung von hetero-dimeren immunglobulinen |
| NZ720161A (en) * | 2013-11-04 | 2022-07-29 | Ichnos Sciences SA | Production of t cell retargeting hetero-dimeric immunoglobulins |
-
2013
- 2013-09-25 EP EP18177798.8A patent/EP3401337A1/de not_active Withdrawn
- 2013-09-25 KR KR1020157010732A patent/KR20150076172A/ko not_active Application Discontinuation
- 2013-09-25 CA CA2886036A patent/CA2886036A1/en not_active Abandoned
- 2013-09-25 CA CA3061557A patent/CA3061557A1/en active Pending
- 2013-09-25 CN CN201380061419.1A patent/CN104968685A/zh active Pending
- 2013-09-25 JP JP2015532465A patent/JP2015529236A/ja active Pending
- 2013-09-25 WO PCT/EP2013/069989 patent/WO2014049003A1/en active Application Filing
- 2013-09-25 US US14/431,207 patent/US20150239991A1/en not_active Abandoned
- 2013-09-25 AU AU2013322710A patent/AU2013322710A1/en not_active Abandoned
- 2013-09-25 IN IN139MUN2015 patent/IN2015MN00139A/en unknown
- 2013-09-25 EP EP13766540.2A patent/EP2900696A1/de not_active Ceased
-
2015
- 2015-03-22 IL IL237872A patent/IL237872B/en active IP Right Grant
-
2016
- 2016-04-05 HK HK16103843.5A patent/HK1215950A1/zh unknown
-
2018
- 2018-02-07 JP JP2018020450A patent/JP2018104444A/ja active Pending
- 2018-06-15 AU AU2018204314A patent/AU2018204314B2/en active Active
- 2018-11-30 JP JP2018224809A patent/JP6856610B2/ja active Active
-
2019
- 2019-02-14 US US16/275,821 patent/US20200010568A1/en not_active Abandoned
- 2019-09-09 IL IL269207A patent/IL269207B/en unknown
-
2020
- 2020-03-04 JP JP2020036853A patent/JP2020105203A/ja active Pending
-
2022
- 2022-06-07 JP JP2022092045A patent/JP2022116326A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL269207A (en) | 2019-11-28 |
| EP3401337A1 (de) | 2018-11-14 |
| AU2013322710A1 (en) | 2015-04-16 |
| AU2018204314B2 (en) | 2020-05-14 |
| CA3061557A1 (en) | 2014-04-03 |
| CN104968685A (zh) | 2015-10-07 |
| AU2018204314A1 (en) | 2018-07-05 |
| IL237872A0 (en) | 2015-05-31 |
| JP6856610B2 (ja) | 2021-04-07 |
| WO2014049003A1 (en) | 2014-04-03 |
| JP2018104444A (ja) | 2018-07-05 |
| HK1215950A1 (zh) | 2016-09-30 |
| JP2015529236A (ja) | 2015-10-05 |
| IL237872B (en) | 2019-09-26 |
| JP2020105203A (ja) | 2020-07-09 |
| US20200010568A1 (en) | 2020-01-09 |
| IL269207B (en) | 2022-02-01 |
| AU2013322710A2 (en) | 2015-05-07 |
| KR20150076172A (ko) | 2015-07-06 |
| JP2022116326A (ja) | 2022-08-09 |
| CA2886036A1 (en) | 2014-04-03 |
| JP2019073512A (ja) | 2019-05-16 |
| US20150239991A1 (en) | 2015-08-27 |
| EP2900696A1 (de) | 2015-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015MN00139A (de) | ||
| WO2013138793A3 (en) | Affinity reagants for protein purification | |
| PH12014501108A1 (en) | Anti-il-36r antibodies | |
| HK1211297A1 (en) | Binding proteins comprising at least two repeat domains against her2 her2 | |
| IL254652A0 (en) | Unnatural albumin binding sites | |
| EA201791693A1 (ru) | Гетеродимерные иммуноглобулины | |
| PH12014502406A1 (en) | Anti-il-23p19 antibodies | |
| MX343858B (es) | Anticuerpos anti-il-23. | |
| TN2015000124A1 (en) | Compositions and methods for antibodies targeting epo | |
| HK1208236A1 (en) | Antigen binding proteins that bind ccr2 ccr2 | |
| EP2883882A4 (de) | Proteinaufreinigungsverfahren | |
| MX343659B (es) | Proteínas de unión receptoras fc. | |
| HK1198832A1 (en) | Fn14 binding proteins and uses thereof fn14 | |
| SI2598516T1 (sl) | Postopek za čiščenje proteinov | |
| IL229722A0 (en) | Dimeric binding proteins based on modified ubiquitin | |
| EP3067367A4 (de) | Verfahren zur aufreinigung rekombinanter proteine | |
| PH12015500752A1 (en) | Her3 antigen binding proteins binding to the beta-hairpin of her3 | |
| MX2014001766A (es) | Anticuerpos de neuregulina y sus usos. | |
| WO2013093627A3 (en) | In silico affinity maturation | |
| MX2015004892A (es) | Metodos y composiciones que se relacionan con anticuerpos de receptor anti-il-21. | |
| TN2014000207A1 (en) | Anti il-36r antibodies | |
| TN2013000186A1 (en) | Anti-il-23 antibodies |